Free US stock education platform offering courses, webinars, and one-on-one coaching to help investors develop winning strategies. Our educational content ranges from basic investing principles to advanced technical analysis techniques used by professionals.
As of 2026-04-08, Keros Therapeutics Inc. (KROS) is trading at a current price of $12.5, marking a 2.12% gain on the day. This analysis examines key technical levels, recent market context, and potential future scenarios for the biotech stock, with no recent earnings data available for the company as of this publication. KROS has seen relatively range-bound trading in recent weeks, with price action largely tied to broader biotech sector flows rather than company-specific news. Key takeaways for
Is Keros Therapeutics (KROS) Stock heavily shorted | Price at $12.50, Up 2.12% - Low Risk Entry
KROS - Stock Analysis
3092 Comments
685 Likes
1
Roine
Active Contributor
2 hours ago
I don’t know why, but this feels urgent.
👍 111
Reply
2
Erha
Legendary User
5 hours ago
This deserves to be celebrated. 🎉
👍 137
Reply
3
Mesha
Power User
1 day ago
Ah, missed the opportunity. 😔
👍 114
Reply
4
Henoc
Power User
1 day ago
That made me spit out my drink… in a good way. 🥤💥
👍 198
Reply
5
Roverta
Engaged Reader
2 days ago
Highlights the importance of volume and momentum nicely.
👍 91
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.